These findings indicate that the SPANX-A/D protein family may have implications beyond immunotherapy and represent previously unrecognised functions for tumour cell biology, which will be crucial to develop new therapeutic targets for skin tumours. The gene discussed is SPANXA1; the disease is skin neoplasm.